PlainRecalls
FDA Drug Moderate Class II Ongoing

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

Reported: January 28, 2026 Initiated: December 30, 2025 #D-0295-2026

Product Description

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

Reason for Recall

Subpotent Drug: Due oxidation caused by leakage of the contents of the Icosapent Ethyl 1g capsules. Use of the affected product may lead to inconsistent therapeutic effects and an increase in potential gastrointestinal side effects in some patients.

Details

Units Affected
22,896 bottles
Distribution
US Nationwide.
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07. Recalled by Zydus Pharmaceuticals (USA) Inc. Units affected: 22,896 bottles.
Why was this product recalled?
Subpotent Drug: Due oxidation caused by leakage of the contents of the Icosapent Ethyl 1g capsules. Use of the affected product may lead to inconsistent therapeutic effects and an increase in potential gastrointestinal side effects in some patients.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 28, 2026. Severity: Moderate. Recall number: D-0295-2026.